Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (16)

2024

  1. Apolipoprotein E-ϵ2 and Resistance to Atherosclerosis in Midlife: The PESA Observational Study

    Circulation Research, Vol. 134, Núm. 4, pp. 411-424

  2. Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults

    European Heart Journal Cardiovascular Imaging, Vol. 25, Núm. 7, pp. 968-975

  3. Coronary Microvascular Function in Asymptomatic Middle-Aged Individuals With Cardiometabolic Risk Factors

    JACC: Cardiovascular Imaging

  4. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

  5. Unidirectional association of clonal hematopoiesis with atherosclerosis development

    Nature Medicine, Vol. 30, Núm. 10, pp. 2857-2866

2023

  1. Cardiac Insulin Resistance in Subjects With Metabolic Syndrome Traits and Early Subclinical Atherosclerosis

    Diabetes Care, Vol. 46, Núm. 11, pp. 2050-2057

  2. Coronary angiography in patients without ST-segment elevation following out-of-hospital cardiac arrest. COUPE clinical trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 2, pp. 94-102

  3. Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years

    Journal of the American College of Cardiology, Vol. 82, Núm. 22, pp. 2069-2083

  4. Early insulin resistance in normoglycemic low-risk individuals is associated with subclinical atherosclerosis

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  5. Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)

    American Journal of Cardiology, Vol. 190, pp. 32-40

  6. Impact of annual volume of cases and intensive cardiac care unit availability on mortality of patients with acute myocardial infarction-related cardiogenic shock treated at revascularization capable centres

    European Heart Journal: Acute Cardiovascular Care, Vol. 12, Núm. 7, pp. 422-429

  7. Post-COVID-19 syndrome and diabetes mellitus: a propensity-matched analysis of the International HOPE-II COVID-19 Registry

    Frontiers in Endocrinology, Vol. 14

  8. Subclinical atherosclerosis and accelerated epigenetic age mediated by inflammation: a multi-omics study

    European heart journal, Vol. 44, Núm. 29, pp. 2698-2709

2022

  1. Effects of a comprehensive lifestyle intervention on cardiovascular health: the TANSNIP-PESA trial

    European heart journal, Vol. 43, Núm. 38, pp. 3732-3745

2017

  1. Nutritional preconditioning by marine omega-3 fatty acids in patients with ST-segment elevation myocardial infarction: A METOCARD-CNIC trial substudy

    International Journal of Cardiology, Vol. 228, pp. 828-833

2014

  1. A polypill strategy to improve adherence

    Journal of the American College of Cardiology, Vol. 64, Núm. 20, pp. 2071-2082